I've been reading about mitochondria long enough now to know the pattern: the most interesting health stories aren't about forcing your cells to work harder — they're about getting the cleanup crew working again. Mitochondria wear out. When the worn ones pile up instead of getting recycled, the whole energy system runs dirty. The recycling process has a name — mitophagy — and it slows down with age.
That's what pulled me into urolithin A. It's not a drug and not something you eat directly. It's made inside you: when you eat pomegranates, berries, or walnuts, your gut bacteria convert their polyphenols into urolithin A, which then flips the mitophagy switch. At least, that's how it works — if you have the right gut bacteria. More on that catch in a minute. What got my attention is that this one now has human trials behind it. Not mouse trials. Human ones.
Trial one: stronger legs in four months
The biggest one is called ATLAS, published in Cell Reports Medicine in 2022. Researchers randomized 88 untrained, overweight middle-aged adults into three groups — two receiving the purified compound, one receiving a placebo — for four months. Nobody changed their diet or exercise routine during the study.
Source: Cell Reports Medicine.
Leg muscle strength went up roughly 12% in one of the urolithin A groups versus placebo — and here's the part that raised my eyebrows: the placebo group's strength actually declined about 10% over those same four months. Blood markers told the same story: acylcarnitines and C-reactive protein fell significantly, which the researchers read as better mitochondrial efficiency and lower inflammation. Muscle biopsies showed increased mitophagy proteins. And the compound was safe and well-tolerated.
Trial two: endurance in older adults — with honest fine print
The second trial, published in JAMA Network Open in 2022, looked at 66 adults aged 65 to 90 over four months. The urolithin A group showed significantly better muscle endurance — more repeated contractions before fatigue in both hand and leg muscles — plus improved blood biomarkers of mitochondrial health.
Source: PubMed / JAMA Network Open.
Here's the fine print, because this site does honesty, not hype: the study's primary endpoints — six-minute walking distance and maximal ATP production in the hand muscle — did not reach statistical significance against placebo. So this is not a "miracle compound" story. It's an endurance-and-biomarkers story, which is still meaningful at our age — endurance is what keeps you independent.
Trial three: immune cells that act younger
The newest one landed in Nature Aging in 2025. Fifty healthy adults aged 45 to 70 took purified urolithin A or a placebo for 28 days. This time the target was the immune system — because immune cells run on mitochondria too, and aging immune cells lean toward exhaustion and inflammation.
The researchers found the urolithin A group's CD8+ T cells shifted toward a "ready-to-respond" state: more naïve-like cells, better fat-and-amino-acid burning capacity (up nearly 15 percentage points), and reduced markers of exhaustion. Natural killer cells showed metabolic gains as well.
Source: News-Medical / Nature Aging.
One honest note: 28 days and 50 people is small and short, and the study didn't measure actual infection or vaccine outcomes — just the cellular machinery underneath. Promising biology, not yet proof of real-world benefit.
The catch: most guts can't make enough of it
Here's the twist that matters most. A crossover trial gave people pomegranate juice and measured who actually converted it into urolithin A. Only about 40% were strong producers. The other 60% were poor converters or couldn't convert it at all — same juice, wildly different results, all depending on the bacteria in their gut. But when the same people took the purified compound directly, circulating levels were uniform and predictable across everyone, regardless of microbiome.
Source: Nature / European Journal of Clinical Nutrition.
So no — eating more pomegranates isn't a reliable strategy. Your microbiome decides whether you benefit, and most people don't benefit enough. That's exactly why the trials all used the purified compound, not juice.
What stuck with me is the shape of this story. Urolithin A isn't about pushing harder — it's about restoring cleanup. Mitophagy is one of those quiet maintenance processes that declines with age, and here's a food-derived molecule that appears to nudge it back toward its younger settings. Human data, multiple trials, real functional endpoints, honest limitations. That's the kind of evidence I pay attention to.
This isn't medical advice, and supplements deserve a conversation with your doctor — especially at our age, with medications in the mix. But if you're following mitochondrial health at all, urolithin A is one of the few compounds where the human evidence is actually starting to stack up. I'll be watching where this goes.
Next read: Always Tired? Your Mitochondria Might Need These 7 — the seven helpers researchers are looking at for mitochondrial support, and how I see this one fitting in with them.
If pieces like this help, get the next one by email — a short note whenever a new article is published.
Want to talk it through? I do free 30-minute phone calls — no pitch, just a conversation about where you are in your own energy journey. Weekdays, 10 AM–7 PM Central.